TCRT ALAUNOS THERAPEUTICS INC Capital Structure Changes 8-K Filing 2025 - Stock Offering On April 11, 2025, Alaunos Therapeutics entered into a Subscription Agreement to sell 500 shares of Series A-1 Convertible Preferred Stock at $1,000 each, totaling $500,000, with a 10% annual dividend rate.Get access to all SEC 8-K filings of the ALAUNOS THERAPEUTICS INC